Tonix Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.

About TNXP

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. 

CEO
Seth Lederman
CEOSeth Lederman
Employees
142
Employees142
Headquarters
Berkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded
2007
Founded2007
Employees
142
Employees142

TNXP Key Statistics

Market cap
238.02M
Market cap238.02M
Price-Earnings ratio
-0.93
Price-Earnings ratio-0.93
Dividend yield
Dividend yield
Average volume
485.01K
Average volume485.01K
High today
$12.74
High today$12.74
Low today
$11.80
Low today$11.80
Open price
$12.32
Open price$12.32
Volume
468.40K
Volume468.40K
52 Week high
$69.97
52 Week high$69.97
52 Week low
$9.40
52 Week low$9.40

Stock Snapshot

Tonix Pharmaceuticals(TNXP) stock is priced at $12.03, giving the company a market capitalization of 238.02M. It carries a P/E multiple of -0.93.

On 2026-08-12, Tonix Pharmaceuticals(TNXP) stock moved within a range of $11.80 to $12.74. With shares now at $12.03, the stock is trading +1.9% above its intraday low and -5.6% below the session's peak.

Trading activity shows a volume of 468.4K, compared to an average daily volume of 485.01K.

The stock's 52-week range extends from a low of $9.40 to a high of $69.97.

The stock's 52-week range extends from a low of $9.40 to a high of $69.97.

TNXP News

Simply Wall St 23h
Tonix Pharmaceuticals Revenue Surge Meets Persistent Cash Burn Concerns

Tonix Pharmaceuticals Holding came into this earnings print with a choppy recent run, roughly flat over the past week and down about 11% over three months. The...

Tonix Pharmaceuticals Revenue Surge Meets Persistent Cash Burn Concerns
TipRanks 2d
Tonix Pharmaceuticals: Stronger-Than-Expected Tonmya Launch, Expanded Market Access, and Advancing Pipeline Underpin Buy Rating

Tonix Pharma, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Stacy Ku from TD Cowen maintained a Buy rating on the sto...

TipRanks 2d
Tonix Pharmaceuticals Earnings Call Highlights Surging TONMYA Momentum

Tonix Pharmaceuticals ((TNXP)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tool...

More TNXP News

Simply Wall St 5d
Insider Buyers At Tonix Pharmaceuticals Holding Recover Some Losses, But Still Down US$57k

Insiders who purchased US$442.6k worth of Tonix Pharmaceuticals Holding Corp. ( ) shares over the past year recouped some of their losses after price gained 20%...

Insider Buyers At Tonix Pharmaceuticals Holding Recover Some Losses, But Still Down US$57k

People also own

Based on the portfolios of people who own TNXP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.